Wilson Sonsini Goodrich & Rosati represented Regie.ai on the Series A transaction. Regie, the generative AI software-as-a-service (SaaS) platform, announced that it has closed its $20.8...
Regie’s $20.8 Million Series A Investment
Urgent.ly’s Merger With Otonomo
Wilson Sonsini and Herzog Fox represented Urgent.ly, while Latham & Watkins and Gross Kleinhendler represented Otonomo. Urgent.ly, Inc. (“Urgently”) and Otonomo Technologies Ltd. announced that they have entered...
GE HealthCare’s Acquisition of Caption Health
Wilson Sonsini Goodrich & Rosati advised Caption Health on the acquisition. GE HealthCare, a leading global precision care innovator, announced that it has signed an agreement...
Micron’s $1.25 Billion Senior Notes Offering
Wilson Sonsini advised Micron, and Simpson Thacher advised the underwriters. Micron Technology, Inc. announced the public offering of $750 million aggregate principal amount of 5.875% Senior...
RingCentral’s Partnership with Avaya
Wilson Sonsini Goodrich & Rosati advised RingCentral on the transaction. RingCentral, Inc, a leading provider of global enterprise cloud communications, video meetings, collaboration, and contact center...
Nextracker’s Initial Public Offering
Wilson Sonsini represented underwriters on the deal while Sidley represented Flex Ltd. and Nextracker Inc. Flex Ltd. announced that its subsidiary, Nextracker Inc., priced its upsized...
Pearl Health’s $75 Million Series B
Wilson Sonsini advised a16z on the deal. Pearl Health, a leading technology company focused on physician enablement and risk bearing in value-based care, announced it has...
Pacific Biosciences’ $201.25 Million Stock Offering
Wilson Sonsini advised Pacific Biosciences of California on the offering, and Davis Polk advised the representatives of the several underwriters involved. Pacific Biosciences of California Inc. announced...
Spatial Labs’ $10 Million Seed Financing
Wilson Sonsini advised Spatial Labs on the deal. Spatial Labs, a web3 infrastructure and hardware company founded by Iddris Sandu, announced $10 million in seed funding...
Alleviant Medical’s $75 Million Equity Financing
Wilson Sonsini Goodrich & Rosati represented Alleviant Medical in the transaction. Alleviant Medical, Inc., a privately-held medical device company developing a no-implant interatrial shunt for heart...
Cheche Technology’s Business Combination with Prime Impact Acquisition I
Wilson Sonsini advised Cheche Technology on the deal. Cheche Technology Inc. (Cheche Technology), China’s leading automotive insurance technology platform, and Prime Impact Acquisition I (Prime Impact),...
FARO Technologies’ Convertible Senior Notes Offering
Wilson Sonsini represented FARO in the offering. FARO Technologies, Inc., a global leader in 4D digital reality, closed its convertible senior note offering of $75 million aggregate...